Literature DB >> 16639020

The safety of intraocular ketorolac in rabbits.

Eyal Margalit1, Lance J Kugler, Matthew V Brumm, Jane L Meza, Uday B Kompella, Edith R Escobar, Gerald R Christensen.   

Abstract

PURPOSE: To assess the safety of a possible substitute treatment for intraocular steroid injections, intraocular injections of ketorolac tromethamine, one of the nonsteroidal anti-inflammatory drugs, were performed in rabbits.
METHODS: Either 0.5% or 0.25% preservative-free ketorolac tromethamine ophthalmic solution (0.1 mL) was injected into the vitreous of the right eye of 15 rabbits. Physiologic saline solution (BSS; Alcon, Ft. Worth, TX) was injected into the left eye of each rabbit as a control. A standard electroretinogram and intraocular pressure measurements were obtained before injection, and repeated 1 day and 1, 2, 3, and 4 weeks after injection. After 4 weeks, the rabbits were euthanatized and the retinas examined by light and electron microscopy. Differences in the electroretinograms, intraocular pressure, and histopathology between the two eyes were recorded. Further, the elimination half-life of the drug in the vitreous was assessed.
RESULTS: There were no statistically significant differences in electroretinograms, or intraocular pressure measurements obtained between the ketorolac-injected eyes and the control eyes. The half life of the drug was measured to be 2.3 hours. No histopathologic changes were observed in study eyes compared with control eyes.
CONCLUSIONS: Preservative-free ketorolac tromethamine is nontoxic to the retinas of rabbits when injected intravitreally and could be considered as an alternative to intraocular steroid injections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639020     DOI: 10.1167/iovs.05-0764

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

1.  Suprachoroidal injection of ketorolac tromethamine does not cause retinal damage.

Authors:  Sumeng Liu; Wu Liu; Yaling Ma; Kegao Liu; Meizi Wang
Journal:  Neural Regen Res       Date:  2012-12-15       Impact factor: 5.135

2.  Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery.

Authors:  Miltiadis K Tsilimbaris; Chrysanthi Tsika; George D Kymionis
Journal:  Ther Clin Risk Manag       Date:  2016-02-12       Impact factor: 2.423

3.  Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration.

Authors:  Douglas A Katsev; Cailyn C Katsev; Jen Pinnow; Catherine M Lockhart
Journal:  Clin Ophthalmol       Date:  2017-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.